What we have done so far

Innovative therapies for skin diseases

Maximising the value of your preclinical assets to find a breakthrough therapy for patients.

Our Aim

We are looking for partnering opportunities on new assets (small molecules, biologics or advanced therapies) in research or preclinical development stages that could be useful for the treatment of dermatological diseases.

Preferably, the assets should target immuno-inflammatory pathways or be suitable for dermato-oncological or rare skin indications, and demonstrate strong scientific rationale, including in vitro and in vivo evidences of efficacy, if available.

Our interest

New assets in advanced research or preclinical development stages

What we offer

Access to our expertise in dermatological R&D

Your benefit

Funding and partnership opportunity

Shared goal

Finding innovative therapies for patients

Call Results